MBX Biosciences, Inc. (MBX) Operating cash flow 2023–2025
MBX Biosciences, Inc. (MBX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$79.9MFY2025 · since FY2023: -$32.0M → -$79.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$79.9M | -46.2% |
| FY2024 | -$54.7M | -71.0% |
| FY2023 | -$32.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice